ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CSRT Consort Medical Plc

1,010.00
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Consort Medical Plc LSE:CSRT London Ordinary Share GB0000946276 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,010.00 1,005.00 1,010.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Consort Medical PLC Total Voting Rights (9954X)

01/12/2017 9:00am

UK Regulatory


Consort Medical (LSE:CSRT)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Consort Medical Charts.

TIDMCSRT

RNS Number : 9954X

Consort Medical PLC

01 December 2017

Registered Number 406711

Consort Medical plc (the "Company")

Total Voting Rights

The Company hereby notifies the market of the following disclosure with respect to the share capital and voting rights of the Company:

As at 30 November 2017, the capital of the Company consists of 49,281,431ordinary shares of 10 pence each with voting rights.

Therefore, the total number of voting rights in the Company is 49,281,431.

Enquiries:

Consort Medical plc

   John Ilett, Company Secretary                                               01442 867920 

Consort Medical plc is a leading, global, single source drug and delivery device company (CDMO). We are at the leading edge of innovation and we are committed to investing in patient, clinician and customer driven innovation to create new treatments, new markets and new opportunities.

Our businesses

Bespak is a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectable products, and the manufacture of devices for the point of care diagnostics market. www.bespak.com.

Aesica is a leading provider of finished dose and active pharmaceutical ingredient (API) development and manufacturing services to pharmaceutical partners. www.aesica-pharma.com.

We employ more than 2,000 people globally of which 1,400 are located in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson, Milton Keynes, Cramlington, Queenborough and Hemel Hempstead, German facilities in Monheim and Zwickau and a facility in Pianezza, Italy. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). www.consortmedical.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRWGGCUGUPMGGU

(END) Dow Jones Newswires

December 01, 2017 04:00 ET (09:00 GMT)

1 Year Consort Medical Chart

1 Year Consort Medical Chart

1 Month Consort Medical Chart

1 Month Consort Medical Chart

Your Recent History

Delayed Upgrade Clock